In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Fluidigm raises $18.5mm from over a hundred investors

Executive Summary

Fluidigm (produces integrated fluid circuits, instrumentation, and software for gene expression quantification, protein crystallization, and other applications) has grossed $18.5mm through the sale of stock to 101 investors. According to the Form D, the company could bring in an additional $5.6mm through this offering.
Deal Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register